Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02178514
Other study ID # 11.20.INF
Secondary ID
Status Completed
Phase N/A
First received June 26, 2014
Last updated January 29, 2018
Start date December 2014
Est. completion date May 2017

Study information

Verified date January 2018
Source Nestlé
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Our main research question is: Do infants fed with BabyNes Nutrition System grow in agreement with the WHO reference?

Our second question is: Do infants fed with BabyNes Nutrition System have a metabolic profile closer to breastfed infants?

In order to answer both questions an observational trial will be carried out for 12 months in order to measure weight and to calculate the weight for age z-scores according to the WHO reference.

A breastfeeding group will be used as reference for the metabolic parameters measured in blood of infants from Chinese background.

The effect of the Babynes formulas will be compared to the metabolic values obtained from this breast-feeding reference group.


Description:

Design:

12 months-study, with a breastfeeding group for the comparison of metabolic values obtained from a Chinese Reference population.

Number of subjects:

In total, 120 subjects shall be enrolled. 80 subjects will be assigned in formula fed group and 40 subjects to breast feeding group. 20% dropouts are already considered for the sample size of 120.

Product(s) to be tested:

For formula fed group:

- BabyNes 1 months: 0-1 month of age

- BabyNes 2 months: 1-2 months of age

- BabyNes 3-6 months: 3-6 months of age

- BabyNes 7-12 months: 7-12 months of age

For breast feeding group:

- Nan HA 1 once the mothers are no more breastfed from 4 months until 6 months old.

- Nan HA 2 once the mothers are no more breastfed from 6 months until 1 year old.

Amount, dosage, route of administration, duration of study product:

Subjects are included in the study for duration of upto 1 year old of the infant.

For FF group:

From birth to 4 months, they are exclusively fed with the infant formula dispenser (ad libitum).

From 4 months of age they can start diversification but they maintain the adapted infant formula to the age until 12 months.

For BF group:

Mothers are encouraged to exclusively breast feed the infant up to 6 months old or at least until 4 months old. From 4 months of age, or later than 4 months with no more breastfeeding, they can start Nan HA1 / HA 2 (commercial formula) until the age of 12 months. The amount should be suitable for the age and appetite of the infants.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date May 2017
Est. primary completion date November 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 4 Months
Eligibility Inclusion Criteria:

Healthy newborns, whose mothers had a normal BMI before pregnancy and no diabetes Healthy newborn infant. Full term infant (= 37 weeks gestation and = 42 weeks gestation). Birth weight = 2500 g and = 4500 g. Having obtained his/her signed legal representative's informed consent.

For BF group:

- Exclusively breastfed since birth, the infant's mother agrees to exclusively breast feed her infant until at least to 4th month.

- Baby is 3 months (3 months ± 7 days) at enrollment.

For FF group:

- Infant from birth to 21 days of age at the time of enrollment (the 21st day included).

- The infant's mother has voluntarily elected to exclusively formula feed her infant after enrolment.

Exclusion Criteria:

Congenital illness or malformation that may affect normal growth (especially immunodeficiency).

Newborn whose mother's BMI was abnormal (<18.5 or >23.9) at start of pregnancy. Newborn whose mother has diabetes of type-1 or type-2 or other metabolic disorders.

Newborn whose mother has a chronic infectious disease. Newborn whose parents / caregivers cannot be expected to comply with treatment. Newborn currently participating in another nutritional interventional clinical trial (except for vaccination studies).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Formula fed with BabyNes Nutrition System


Locations

Country Name City State
China Children's Hospital of Fudan University Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Nestlé

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary the change in weight-for-age z-score of the WHO Child Growth Standard from birth to 4 months of age
Secondary the Insulin, C-peptide, IGF-1 leptin and ghrelin level at 4 and 12 months
Secondary length and head circumference measures birth, 1, 2, 4, 6, 9 12 months of age
Secondary Body composition: fat mass, lean mass 4 months and 6 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05551975 - Preterm Infants Fed a Human Milk Fortifier N/A
Completed NCT01162798 - Preterm Infant Growth N/A
Completed NCT01721512 - The Growth and Development of Breast and Formula Fed Term Asian Infants N/A
Active, not recruiting NCT00970398 - Effect of an Infant Formula on Infant Growth, Health and Immune Functions N/A
Completed NCT01666457 - Impact of Implementing an Infant Driven Feeding Program on Oral Feeding and Growth Outcomes of Medically Fragile Infants in the Neonatal ICU (NICU)
Completed NCT00808756 - Study on Fermentable Carbohydrates in Healthy Infants N/A
Completed NCT00997971 - Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein Phase 3
Completed NCT03276663 - Growth of Healthy Term Infants Fed a Partially Hydrolyzed Follow-up Formula N/A
Recruiting NCT02695784 - Probiotics After Discharge Phase 4
Withdrawn NCT02860026 - Growth and Tolerance of Healthy Term Infants Fed Cow's Milk-Based Infant Formulas N/A
Completed NCT01128517 - Maternal Education on Complementary Feeding and Infant Outcome N/A
Completed NCT00282113 - Effects of Probiotic and Prebiotic Combinations on Premature Infants N/A
Completed NCT03276884 - Growth and Tolerance of Young Infants N/A
Completed NCT04055363 - Human Milk Oligosaccharides (HMOs) Post-market Study on Infants N/A
Completed NCT05302427 - Infant Massage and Infant Growth, Mother-Infant Attachment, and Maternal Self-Confidence N/A
Not yet recruiting NCT05616117 - Next-generation Effects of Vitamin D Supplementation in Pregnancy
Active, not recruiting NCT02410057 - Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula N/A
Completed NCT01158352 - Study to Evaluate the Effect of Short Treatment With Nutritional Supplementation Standardized Innovative Formula, on Growth and Weight Gain in Short and Lean Prepubertal Children N/A
Completed NCT01109849 - Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth Phase 4
Completed NCT01210391 - Growth of Infants Fed an Extensively Hydrolyzed Infant Formula N/A